Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Medhat Askar, MD, PhD

216.444.2804

Medhat Askar, MD, PhD

Appointed: 2006

Medhat Askar, MD, PhD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code C100
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2804
WorkFax:216.444.8261
Surgeon:
No
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Medhat Askar, MD, PhD, is the Director of Allogen Laboratories and a Staff Physician in the Transplant Center of the Digestive Diseases Institute. He is also Associate Professor in the Department of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

He is board-certified by the American Board of Histocompatibility and Immunogenetics, the American Board of Medical Laboratory Immunology, and the American Board of Bioanalysis in Diagnostic Immunology. His clinical interests include immunology, immunogenetics and transplantation.

Professional Highlights

Dr. Askar's clinical responsibilities as the Director of Allogen Laboratories in Cleveland, Ohio and Charleston, West Virginia include overseeing clinical testing performed for solid organ and stem cell transplant candidates, recipients and donors.

While his primary clinical responsibility is in the area of laboratory supervision, he also provides clinical research support for the transplant services and participates in resident and fellowship educational activities.

Medhat is very active in several roles in the Cleveland Clinic Lerner College of Medicine; including serving as a PBL Facilitator and a faculty member of the first year medical student curriculum in Immunology.He also serves as a member of the CCLCM Admissions Committee and has been the research preceptor for numerous medical students, residents and fellows.

Dr. Askar is a member of many committees within national and international professional organizations including the Education Committee of the Transplantation Society and the Quality and Standards Committee of the American Society for Histocompatibility and Immunogenetics (ASHI). He is a Commissioner of the ASHI Accreditation Review Board and the Vice Chair of the Diplomat Exam Committee of The American Board of Histocompatibility and Immunogenetics. He has authored and co-authored manuscripts in peer reviewed medical journals, a book Chapter, and serves as a reviewer for many high impact transplant journals including the American Journal of Transplantation, The Biology of Blood and Marrow Transplantation, Human Immunology, Transplant Infectious Diseases, and Transplant International.

Education & Fellowships

Fellowship - University of Pittsburgh Medical Center & Children's Hospital of Pittsburgh
Pittsburgh, PA USA
2005
Medical School - Al-Azhar University School of Medicine
Cairo Egypt
2000
Graduate - Al-Azhar University, Cairo,
Egypt
1997
Internship - Ain Shams University Hospitals
Medicine
Cairo Egypt
1995
Medical School - Ain Shams University, Cairo,
Egypt
1993
Doctorate - Al-Azhar University, Cairo,
Egypt

Specialty Interests

Immunogenetics and Transplant Immunology

Additional Training

  • Scholarship of Education in Health Professions, Harvard Macy Institute, Harvard Medical School
  • Fellowship in Medical Education, the Education Institute, Cleveland Clinic
  • Distinguished Educator Certificate, the Education Institute, Cleveland Clinic

Memberships

  • The American Association for the Advancement of Science
  • The Transplantation Society
  • American Society of Transplantation
  • American Society for Blood and Marrow Transplantation
  • American Society for Histocompatibility and Immunogenetics
  • British Society of Histocompatibility and Immunogenetics

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/22/2014, Dr. Askar has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English